Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02347007 · ClinicalTrials.gov registry record · NA

Impact of Almond Supplementation on Body Composition in Overweight/Obese Minority Adults

A NA study of Obesity and Overweight, sponsored by Columbia University.

Completed
Registry status
NA
Development phase
26
Enrollment target
1
Study location

NCT02347007 is a NA study of Obesity and Overweight that has completed, run by Columbia University. The registered enrollment target is 26 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02347007, a NA study of Obesity and Overweight, has completed, sponsored by Columbia University.

COMPLETED
Registry status
NA
Development phase
26 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine whether introducing almonds into the diet of overweight and obese Blacks and Hispanics improves body composition, decreases liver fat, and lowers cardiovascular disease profile.

Interventions

  • DIETARY_SUPPLEMENT Almond
  • DIETARY_SUPPLEMENT Cereal Bar

Study Locations (1)

New York

  • New York Nutrition Obesity Research Center - New York

Trial Details

FieldValue
Enrollment Target 26 participants
Start Date 2014-10
Est. Completion 2019-03
Phase NA

Sponsor

Columbia University

958 total trials

What the Registry Record Tells You About NCT02347007

The ClinicalTrials.gov registry entry for NCT02347007 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (97% lower). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Almond is the first listed.

NCT02347007 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT02347007 about?

NCT02347007 is a clinical study titled "Impact of Almond Supplementation on Body Composition in Overweight/Obese Minority Adults". The purpose of this study is to determine whether introducing almonds into the diet of overweight and obese Blacks and Hispanics improves body composition, decreases liver fat, and lowers cardiovascular disease profile.

What is the current status of trial NCT02347007?

This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2014-10. Estimated completion is 2019-03.

What conditions does trial NCT02347007 study?

This clinical trial studies the following conditions: Obesity, Overweight, Fatty Liver, Metabolic Syndrome X.

What interventions are being tested in trial NCT02347007?

The interventions under investigation include: Almond (DIETARY_SUPPLEMENT), Cereal Bar (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT02347007?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02347007 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.